Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 119-130

  Konecny, Michal ^a   Milly, Miriam ^a   Zavodna, Katarina ^a   Weismanova, Eva ^a   Gregorova, Jaroslava ^a   Mlkva, Iveta ^b   Ilencikova, Denisa ^c   Kausitz, Juraj ^a   Bartosova, Zdena ^a  

^a ST ELIZABETH CANCER INSTITUTE   (Slovakia)

^b FACULTY HOSPITAL   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

BRCA1; BRCA2; Haplotype; Hereditary breast ovarian cancer; MLPA; Mutation; Uncertain variant

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2;

ADULT; ARTICLE; BREAST CANCER; FAMILIAL CANCER; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA, NEOPLASM; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE DELETION; SLOVAKIA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79151472565     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1325-x     Document Type: Article

References (48)

1. Ondrusova M, Plesko I, Safaei-Diba Ch, Obsitnikova A, Stefanakova D, Ondrus D (2007) Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic. Bratislava, National Cancer Registry of the Slovak Republic, NHIC. http://www.nor-sk.org/ (online)
2. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper N Loman H Olsson O Johannsson A Borg B Pasini P Radice S Manoukian DM Eccles N Tang E Olah H Anton-Culver E Warner J Lubinski J Gronwald B Gorski H Tulinius S Thorlacius H Eerola H Nevanlinna K Syrjäkoski OP Kallioniemi D Thompson C Evans J Peto F Lalloo DG Evans DF Easton 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 1:CAS:528:DC%2BD3sXjslagtbg%3D 10.1086/375033 12677558 (Pubitemid 36530000)
3. Y Miki J Swensen D Shattuck-Eidens PA Futruel K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding R Bell J Rosenthal C Hussey T Tran M McClure C Frye T Hattier R Phelps A Haugen-Strano H Katcher K Yakumo Z Gholami D Schaffer S Stone S Bayer C Wray R Bogden P Dayananth J Ward P Tonin S Narod PK Bristow FH Norris L Helvering P Morrison P Rosteck M Lai JC Barrett C Lewis S Neuhausen L Cannon-Albright D Goldgar R Wiseman A Kamb MH Skolnick 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 1:CAS:528:DyaK2MXhtF2ns70%3D 10.1126/science.7545954 7545954 (Pubitemid 24345325)
4. R Wooster SL Neuhausen J Mangion Y Quirk D Ford N Collins K Nguyen S Seal T Tran D Averill 1994 Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13 Science 265 2088 2090 1:CAS:528:DyaK2cXmsFejsLY%3D 10.1126/science.8091231 8091231 (Pubitemid 24325690)
5. DG Cox P Kraft SE Hankinson DJ Hunter 2005 Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer Breast Cancer Res 7 2 R171 R175 1:CAS:528:DC%2BD2MXhtFSltL8%3D 10.1186/bcr973 15743496
6. P Frosk S Burgess T Dyck R Jobse EL Spriggs 2007 The use of ancestral haplotypes in the molecular diagnosis of familial breast cancer Genet Test 11 3 208 215 1:CAS:528:DC%2BD2sXhtF2rtLjE 10.1089/gte.2006.0518 17949280 (Pubitemid 47614405)
7. PL Welcsh MC King 2001 BRCA1 and BRCA2 and the genetics of breast and ovarian cancer Hum Mol Genet 10 705 713 1:CAS:528:DC%2BD3MXjt1ajsb8%3D 10.1093/hmg/10.7.705 11257103 (Pubitemid 32331579)
8. M de la Hoya S Gutiérrez-Enríquez E Velasco A Osorio A Sánchez de Abajo A Vega R Salazar E Esteban G Llort R Gonzalez-Sarmiento, et al. 2006 Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer Clin Chem 52 1480 1485 10.1373/clinchem.2006.070110 (Pubitemid 44150532)
9. A Petrij-Bosch T Peelen M van Vliet R van Eijk R Olmer M Drusedau FB Hogervorst S Hageman PJ Arts MJ Lingtenberg, et al. 1997 BRCA genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 17 341 355 1:CAS:528:DyaK2sXntVSqtLk%3D 10.1038/ng1197-341 9354803 (Pubitemid 27476002)
10. SA Narod WD Foulkes 2004 BRCA1 and BRCA2: 1994 and beyond Nature Rev 4 665 676 1:CAS:528:DC%2BD2cXntFCmsbk%3D
11. LS Friedman EA Ostermeyer CI Szabo P Dowd ED Lynch SE Rowell MC King 1994 Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families Nat Genet 8 399 404 1:CAS:528:DyaK2MXitl2hsb0%3D 10.1038/ng1294-399 7894493 (Pubitemid 24375608)
12. OligoCalc. http://www.basic.northwestern.edu/biotools/oligocalc.html. Accessed 19 Dec 2010
13. AGVGD. http://agvgd.iarc.fr/agvgdinput.php. Accessed 19 Dec 2010
14. Pmut. http://mmb2.pcb.ub.es:8080/Pmut. Accessed 19 Dec 2010
15. PolyPhen. http://genetics.bwh.harvard.edu/pph. Accessed 19 Dec 2010
16. JT den Dunnen MH Paalman 2003 Standardizing mutation nomenclature: why bother? Hum Mutat 22 3 181 182 10.1002/humu.10262 (Pubitemid 37071634)
17. Breast Cancer Information Core database. http://research.nhgri.nih.gov/ bic/. Accessed 19 Dec 2010
18. MutDb database. http://www.mutdb.org/. Accessed 19 Dec 2010
19. HGMD database. http://www.hgmd.cf.ac.uk/ac/index.php. Accessed 19 Dec 2010
20. Swiss-Prot database. http://expasy.org/sprot/. Accessed 19 Dec 2010
21. M Konecny M Vizvaryova E Weismanova D Ilencikova I Mlkva P Weismann G Machackova J Kausitz 2007 The spectrum and incidence of BRCA1 pathogenic mutations in slovak breast/ovarian cancer families Neoplasma 54 137 142 1:CAS:528:DC%2BD2sXlvF2mu74%3D 17319787
22. S Cierniková M Tomka O Sedláková M Reinerová V Stevurková M Kovác M Cente D Ilenciková V Bella V Zajac 2003 The novel exon 11 mutation of BRCA1 gene in a high-risk family Neoplasma 50 6 403 407 14689060 (Pubitemid 38009579)
23. M Konecny M Vizvaryova K Zavodna R Behulova M Gerykova-Bujalkova T Krivulcik F Cisarik J Kausitz E Weismanova 2010 Identification of a novel mutations BRCA1*c.80+3del4 and BRCA2*c.6589delA in Slovak HBOC families Breast Cancer Res Treat 119 1 233 237 1:CAS:528:DC%2BD1MXhsFaqtr3L 10.1007/s10549-008-0244-6 19011960
24. TM Wagner RA Moslinger D Muhr G Langbauer K Hirtenlehner H Concin W Doeller A Haid AH Lang P Mayer E Ropp E Kubista B Amirimani T Helbich A Becherer O Scheiner H Breiteneder A Borg P Devilee P Oefner C Zielinski 1998 BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics Int J Cancer 77 354 360 1:CAS:528:DyaK1cXkt1GisLk%3D 10.1002/(SICI)1097-0215(19980729)77:3<354:: AID-IJC8>3.0.CO;2-N 9663595 (Pubitemid 28299869)
25. E Machackova L Foretova M Lukesova P Vasickova M Navratilova I Coene H Pavlu V Kosinova J Kuklova K Claes 2008 Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer BMC Cancer 8 140 10.1186/1471-2407-8-140 18489799 (Pubitemid 351803802)
26. A Russo V Calò V Agnese L Bruno S Corsale C Augello G Gargano F Barbera S Cascio C Intrivici G Rinaldi G Gulotta M Macaluso E Surmacz A Giordano N Gebbia V Bazan 2007 BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses Breast Cancer Res Treat 105 3 267 276 1:CAS:528:DC%2BD2sXhtFSlsr3O 10.1007/s10549-006-9456-9 17221156 (Pubitemid 47596445)
27. G Llort CY Munoz MP Tuser IB Guillermo JR Lluch AE Bale MA Franco 2002 Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain Hum Mutat 19 307 10.1002/humu.9014 11857748
28. M Krajc E Teugels J Zgajnar G Goelen N Besic S Novakovic M Hocevar J de Grève 2008 Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families BMC Med Genet 9 83 10.1186/1471-2350-9-83 18783588
29. MD Miramar MT Calvo A Rodriguez A Antón F Lorente E Barrio A Herrero J Burriel A García de Jalón 2008 Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1 Breast Cancer Res Treat 112 2 353 358 1:CAS:528:DC%2BD1cXht1Cms73E 10.1007/s10549-007-9868-1 18176857
30. M Perkowska I Brozek B Wysocka K Haraldsson T Sandberg U Johansson G Sellberg A Borg J Limon 2003 BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland Hum Mutat 2 553 554 10.1002/humu.9139
31. A Bergman A Flodin Y Engwall EL Arkblad K Berg Z Einbeigi T Martinsson J Wahlstrom P Karlsson M Nordling 2005 A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques Fam Cancer 4 89 96 1:CAS:528:DC%2BD2MXltFGqsL8%3D 10.1007/s10689-004-5812-2 15951958 (Pubitemid 40897808)
32. H Vezina F Durocher M Dumont L Houde C Szabo M Tranchant J Chiquette M Plante R Laframboise J Lepine H Nevanlinna D Stoppa-Lyonnet D Goldgar P Bridge J Simard 2005 Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families Hum Genet 117 119 132 1:CAS:528:DC%2BD2MXltlCisL8%3D 10.1007/s00439-005-1297-9 15883839 (Pubitemid 43136788)
33. H Ruffner CA Joazeiro D Hemmatim T Hunter IM Verma 2001 Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity Proc Natl Acad Sci USA 98 9 5134 5139 1:CAS:528:DC%2BD3MXjt1Ons7s%3D 10.1073/pnas.081068398 11320250 (Pubitemid 32397095)
34. P Pohlreich M Zikan J Stribrna Z Kleibl M Janatova J Kotlas J Zidovska J Novotny L Petruzelka C Szabo B Matous 2005 High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area Breast Cancer Res 7 728 736 10.1186/bcr1282
35. A Kataki I Gomatos N Pararas A Armakolas D Panousopoulos G Karantzikos D Voros G Zografos C Markopoulos E Leandros M Konstadoulakis 2005 Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals-correlation with clinicopathological data Clin Genet 67 4 322 329 1:STN:280:DC%2BD2M7gtlajug%3D%3D 10.1111/j.1399-0004. 2004.00400.x 15733268 (Pubitemid 40424828)
36. L Foretova E Machackova M Navratilova H Pavlu M Hruba M Lukesova D Valik 2004 BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic Hum Mutat 23 397 398 10.1002/humu.9226 15024741
37. P Vasickova E Machackova M Lukesova J Damborsky O Horky H Pavlu J Kuklova V Kosinova M Navratilova L Foretova 2007 High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic BMC Med Genet 8 32 10.1186/1471-2350-8-32 17561994 (Pubitemid 47040199)
38. C Hartmann AL John R Klaes W Hofmann R Bielen R Koehler B Janssen CR Bartram N Arnold J Zschocke 2004 Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families Hum Mutat 24 6 534 10.1002/humu.9291 15532023
39. S Engert B Wappenschmidt B Betz K Kast M Kutsche H Hellebrand TO Goecke M Kiechle D Niederacher RK Schmutzler A Meindl 2008 MLPA screening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases Hum Mutat 29 7 948 958 1:CAS:528:DC%2BD1cXpt1Ortrk%3D 10.1002/humu.20723 18431737 (Pubitemid 351951289)
40. O Díez A Osorio M Durán JI Martinez-Ferrandis M de la Hoya R Salazar A Vega B Campos R Rodríguez-López E Velasco J Chaves E Díaz-Rubio J Jesús Cruz M Torres E Esteban A Cervantes C Alonso JM San Román R González-Sarmiento C Miner A Carracedo M Eugenia Armengod T Caldés J Benítez M Baiget 2003 Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects Hum Mutat 22 4 301 312 10.1002/humu.10260 12955716 (Pubitemid 37210855)
41. D Purnomosari G Pals A Wahyono T Aryandono TW Manuaba SJ Haryono PJ van Diest 2007 BRCA1 and BRCA2 germline mutation analysis in the Indonesian population Breast Cancer Res Treat 106 2 297 304 1:CAS:528:DC%2BD2sXht1CgtL7P 10.1007/s10549-006-9493-4 17972177 (Pubitemid 350045016)
42. AA Tesoriero EM Wong MA Jenkins JL Hopper MA Brown G Chenevix-Trench AB Spurdle MC Southey kConFab 2005 Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families Hum Mutat 26 5 495 1:STN:280:DC%2BD2MrlsVSqsQ%3D%3D 10.1002/humu.9379 16211554
43. T Pal J Permuth-Wey JA Betts JP Krischer J Fiorica H Arango J LaPolla M Hoffman MA Martino K Wakeley G Wilbanks S Nicosia A Cantor R Sutphen 2005 BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases Cancer 104 12 2807 2816 1:CAS:528:DC%2BD28XptlSrsA%3D%3D 10.1002/cncr.21536 16284991 (Pubitemid 41798292)
44. G Chenevix-Trench S Healey S Lakhani P Waring M Cummings R Brinkworth AM Deffenbaugh LA Burbidge D Pruss T Judkins T Scholl A Bekessy A Marsh P Lovelock M Wong A Tesoriero H Renard M Southey JL Hopper K Yannoukakos M Brown D Easton SV Tavtigian D Goldgar AB Spurdle kConFab Investigators 2006 Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance Cancer Res 66 4 2019 2027 1:CAS:528:DC%2BD28XhsFamu74%3D 10.1158/0008-5472.CAN-05-3546 16489001 (Pubitemid 43294910)
45. PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder 2002 Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33 36 1:CAS:528:DC%2BD38Xjt1Kgu7g%3D 10.1038/ng853 11984562
46. AC Antoniou PP Pharoah P Smith DF Easton 2004 The BOADICEA model of genetic susceptibility to breast and ovarian cancer Br J Cancer 91 8 1580 1590 1:CAS:528:DC%2BD2cXotlCkur8%3D 15381934 (Pubitemid 39486366)
47. VS Syamala L Sreeja V Syamala PB Raveendran R Balakrishnan R Kuttan R Ankathil 2008 Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival Fam Cancer 7 3 213 220 1:CAS:528:DC%2BD1cXptVKksb0%3D 10.1007/s10689-007-9177-1 18080216
48. BD Ward BC Hendrickson T Judkins AM Deffenbaugh B Leclair BE Ward T Scholl 2005 A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets J Mol Diagn 7 1 139 142 1:CAS:528:DC%2BD2MXhvFKrt7k%3D 15681486 (Pubitemid 40310177)